CTCL
Showing 151 - 175 of 175
Atopic Dermatitis, Psoriasis, Alopecia Trial in Ann Arbor (UVA1 Irradiation, UVB Irradiation)
Terminated
- Atopic Dermatitis
- +6 more
- UVA1 Irradiation
- UVB Irradiation
-
Ann Arbor, MichiganUniversity of Michigan Department of Dermatology
May 21, 2015
Cutaneous T-cell Lymphoma Trial in New Taipei City (HITS)
Unknown status
- Cutaneous T-cell Lymphoma
- HITS
-
New Taipei City, TaiwanFar Eastern Memorial Hospital
Aug 1, 2014
Cutaneous T-Cell Lymphoma Trial in Minneapolis (skin biopsy)
Terminated
- Cutaneous T-Cell Lymphoma
- skin biopsy
-
Minneapolis, MinnesotaUniversity of Minnesota
Mar 28, 2014
Lymphoma Trial in Birmingham, Durham, Houston (forodesine HCl)
Completed
- Lymphoma
- forodesine hydrochloride
-
Birmingham, Alabama
- +2 more
May 29, 2013
Stable Angina Pectoris, Unstable Angina Pectoris, Silent Ischemia Trial in Morristown (Photopheresis Post Angioplasty)
Terminated
- Stable Angina Pectoris
- +2 more
- Photopheresis Post Angioplasty
-
Morristown, New JerseyMorristown Memorial Hospital
Jan 15, 2014
NSCLC Trial in Morristown (Extracorporeal Photochemo With Transimmunization)
Terminated
- Non-Small Cell Lung Cancer
- Extracorporeal Photochemotherapy With Transimmunization
-
Morristown, New JerseyMorristown Memorial Hospital
Jan 15, 2014
Parapsoriasis Trial in Philadelphia (Bexarotene 1% gel)
Terminated
- Parapsoriasis
- Bexarotene 1% gel
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Apr 15, 2013
Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma Trial in Chicago
Completed
- Anaplastic Large Cell Lymphoma
- +13 more
-
Chicago, IllinoisCancer and Leukemia Group B
Jan 15, 2013
Anaplastic Large-Cell Lymphoma Trial in New York (Denileukin Diftitox, Denileukin diftitox, ifosfamide, cyclophosphamide,
Withdrawn
- Anaplastic Large-Cell Lymphoma
- Denileukin Diftitox
- Denileukin diftitox, ifosfamide, cyclophosphamide, etoposide
-
New York, New YorkColumbia University Medical Center
May 14, 2013
Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Cutaneous T-cell
Terminated
- Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
- +2 more
- O6-benzylguanine
- +2 more
-
Cleveland, OhioCase Western Reserve University
Jan 10, 2013
Mycosis Fungicides, Sezary Syndrome, Dermatitis Trial in Creteil (Detection of KIR receptor by RT PCR)
Completed
- Mycosis Fungicides
- +3 more
- Detection of KIR receptor by RT PCR
-
Creteil, FranceGroupe hospitalier Henri Mondor - Albert Chenevier
Aug 21, 2012
Mycosis Fungoides, Sezary Syndrome Trial in Worldwide (HuMax-CD4 (zanolimumab))
Terminated
- Mycosis Fungoides
- Sezary Syndrome
- HuMax-CD4 (zanolimumab)
-
Birmingham, Alabama
- +34 more
Jul 24, 2012
Soft Tissue Sarcoma Trial in Lyon (LBH589 (Panobinostat®))
Completed
- Soft Tissue Sarcoma
- LBH589 (Panobinostat®)
-
Lyon, FranceCentre Léon Berard
Mar 5, 2013
Mycosis Fungoides Trial in United States (mechlorethamine-MCH (nitrogen mustard))
Completed
- Mycosis Fungoides
- mechlorethamine-MCH (nitrogen mustard)
-
Stanford, California
- +11 more
Oct 2, 2012
Alopecia Areata Trial in Houston (Targretin Gel 1%)
Completed
- Alopecia Areata
- Targretin Gel 1%
-
Houston, TexasUT MD Anderson Cancer Center
Aug 1, 2012
Cutaneous T-cell Lymphoma (CTCL), Trial in Worldwide (Forodesine 200 mg)
Completed
- Cutaneous T-cell Lymphoma (CTCL),
- Forodesine 200 mg
-
Birmingham, Alabama
- +40 more
Jan 18, 2012
Study the Disease Course in Cutaneous T-Cell Lymphoma
Completed
- Lymphoma
- gene rearrangement analysis
- +5 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Mar 14, 2012
Lymphoma Trial in United States (proteomic profiling)
Completed
- Lymphoma
- proteomic profiling
-
Stanford, California
- +3 more
Mar 14, 2012
Cutaneous T-Cell Lymphoma Trial in Montreal (Tazarotene)
Unknown status
- Cutaneous T-Cell Lymphoma
-
Montreal, Quebec, CanadaMcGill University
Oct 22, 2008
Leukemia, T-Cell, Lymphoma, T-Cell, Cutaneous Trial run by the NCI (Yttrium-90 radiolabeled anti-Tac antibody)
Completed
- Leukemia, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Yttrium-90 radiolabeled anti-Tac antibody
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Cutaneous T-Cell Lymphoma Trial in Boston (bexarotene, photopheresis)
Completed
- Cutaneous T-Cell Lymphoma
- bexarotene
- photopheresis
-
Boston, MassachusettsBoston University Medical Center
Mar 23, 2006